Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups

The HLA class II (DRB1 and DQB1) associations with sarcoidosis have been studied by several groups but often without consistent results. In this paper, we consider the hypothesis that observed inconsistencies relate to distinct, genetically encoded disease phenotypes which differ in prevalence betwe...

Full description

Saved in:
Bibliographic Details
Published inHuman molecular genetics Vol. 19; no. 20; pp. 4100 - 4111
Main Authors Sato, Hiroe, Woodhead, Felix A., Ahmad, Tariq, Grutters, Jan C., Spagnolo, Paolo, van den Bosch, Jules M.M., Maier, Lisa A., Newman, Lee S., Nagai, Sonoko, Izumi, Takateru, Wells, Athol U., du Bois, Roland M., Welsh, Kenneth I.
Format Journal Article
LanguageEnglish
Published Oxford Oxford University Press 15.10.2010
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The HLA class II (DRB1 and DQB1) associations with sarcoidosis have been studied by several groups but often without consistent results. In this paper, we consider the hypothesis that observed inconsistencies relate to distinct, genetically encoded disease phenotypes which differ in prevalence between centres. We therefore typed HLA-DRB1 and DQB1 in 340 UK, 139 Dutch and 163 Japanese sarcoidosis patients and, respectively, 354, 218 and 168 healthy controls from these populations. We applied consistent phenotyping and genotyping and investigated associations between HLA class II alleles and distinct disease phenotypes within and between ethnic groups. DRB1*01 and DQB1*0501 are protective against all manifestations of sarcoidosis. Lung-predominant sarcoidosis is associated with DRB1*12 and *14. Löfgren's syndrome is a common sarcoidosis phenotype in the Dutch and is strongly associated with the DRB1*0301 allele. This phenotype is not seen among the Japanese in whom DRB1*0301 is absent. The same allele is protective for UK uveitis. Sarcoid uveitis is common in Japan. The DRB1*04–DQB1*0301 haplotype is a risk factor for this disease manifestation in Japanese and UK subjects but protective for sarcoidosis overall. We show that distinct sarcoidosis phenotypes have similar genetic associations across ethnic groups. The disease case mix differs between centres and may be explained by different ethnic allelic frequencies.
AbstractList The HLA class II (DRB1 and DQB1) associations with sarcoidosis have been studied by several groups but often without consistent results. In this paper, we consider the hypothesis that observed inconsistencies relate to distinct, genetically encoded disease phenotypes which differ in prevalence between centres. We therefore typed HLA-DRB1 and DQB1 in 340 UK, 139 Dutch and 163 Japanese sarcoidosis patients and, respectively, 354, 218 and 168 healthy controls from these populations. We applied consistent phenotyping and genotyping and investigated associations between HLA class II alleles and distinct disease phenotypes within and between ethnic groups. DRB1*01 and DQB1*0501 are protective against all manifestations of sarcoidosis. Lung-predominant sarcoidosis is associated with DRB1*12 and *14. Löfgren's syndrome is a common sarcoidosis phenotype in the Dutch and is strongly associated with the DRB1*0301 allele. This phenotype is not seen among the Japanese in whom DRB1*0301 is absent. The same allele is protective for UK uveitis. Sarcoid uveitis is common in Japan. The DRB1*04–DQB1*0301 haplotype is a risk factor for this disease manifestation in Japanese and UK subjects but protective for sarcoidosis overall. We show that distinct sarcoidosis phenotypes have similar genetic associations across ethnic groups. The disease case mix differs between centres and may be explained by different ethnic allelic frequencies.
The HLA class II (DRB1 and DQB1) associations with sarcoidosis have been studied by several groups but often without consistent results. In this paper, we consider the hypothesis that observed inconsistencies relate to distinct, genetically encoded disease phenotypes which differ in prevalence between centres. We therefore typed HLA-DRB1 and DQB1 in 340 UK, 139 Dutch and 163 Japanese sarcoidosis patients and, respectively, 354, 218 and 168 healthy controls from these populations. We applied consistent phenotyping and genotyping and investigated associations between HLA class II alleles and distinct disease phenotypes within and between ethnic groups. DRB1*01 and DQB1*0501 are protective against all manifestations of sarcoidosis. Lung-predominant sarcoidosis is associated with DRB1*12 and *14. Loefgren's syndrome is a common sarcoidosis phenotype in the Dutch and is strongly associated with the DRB1*0301 allele. This phenotype is not seen among the Japanese in whom DRB1*0301 is absent. The same allele is protective for UK uveitis. Sarcoid uveitis is common in Japan. The DRB1*04-DQB1*0301 haplotype is a risk factor for this disease manifestation in Japanese and UK subjects but protective for sarcoidosis overall. We show that distinct sarcoidosis phenotypes have similar genetic associations across ethnic groups. The disease case mix differs between centres and may be explained by different ethnic allelic frequencies.
The HLA class II (DRB1 and DQB1) associations with sarcoidosis have been studied by several groups but often without consistent results. In this paper, we consider the hypothesis that observed inconsistencies relate to distinct, genetically encoded disease phenotypes which differ in prevalence between centres. We therefore typed HLA-DRB1 and DQB1 in 340 UK, 139 Dutch and 163 Japanese sarcoidosis patients and, respectively, 354, 218 and 168 healthy controls from these populations. We applied consistent phenotyping and genotyping and investigated associations between HLA class II alleles and distinct disease phenotypes within and between ethnic groups. DRB1*01 and DQB1*0501 are protective against all manifestations of sarcoidosis. Lung-predominant sarcoidosis is associated with DRB1*12 and *14. Löfgren's syndrome is a common sarcoidosis phenotype in the Dutch and is strongly associated with the DRB1*0301 allele. This phenotype is not seen among the Japanese in whom DRB1*0301 is absent. The same allele is protective for UK uveitis. Sarcoid uveitis is common in Japan. The DRB1*04-DQB1*0301 haplotype is a risk factor for this disease manifestation in Japanese and UK subjects but protective for sarcoidosis overall. We show that distinct sarcoidosis phenotypes have similar genetic associations across ethnic groups. The disease case mix differs between centres and may be explained by different ethnic allelic frequencies.The HLA class II (DRB1 and DQB1) associations with sarcoidosis have been studied by several groups but often without consistent results. In this paper, we consider the hypothesis that observed inconsistencies relate to distinct, genetically encoded disease phenotypes which differ in prevalence between centres. We therefore typed HLA-DRB1 and DQB1 in 340 UK, 139 Dutch and 163 Japanese sarcoidosis patients and, respectively, 354, 218 and 168 healthy controls from these populations. We applied consistent phenotyping and genotyping and investigated associations between HLA class II alleles and distinct disease phenotypes within and between ethnic groups. DRB1*01 and DQB1*0501 are protective against all manifestations of sarcoidosis. Lung-predominant sarcoidosis is associated with DRB1*12 and *14. Löfgren's syndrome is a common sarcoidosis phenotype in the Dutch and is strongly associated with the DRB1*0301 allele. This phenotype is not seen among the Japanese in whom DRB1*0301 is absent. The same allele is protective for UK uveitis. Sarcoid uveitis is common in Japan. The DRB1*04-DQB1*0301 haplotype is a risk factor for this disease manifestation in Japanese and UK subjects but protective for sarcoidosis overall. We show that distinct sarcoidosis phenotypes have similar genetic associations across ethnic groups. The disease case mix differs between centres and may be explained by different ethnic allelic frequencies.
The HLA class II ( DRB1 and DQB1 ) associations with sarcoidosis have been studied by several groups but often without consistent results. In this paper, we consider the hypothesis that observed inconsistencies relate to distinct, genetically encoded disease phenotypes which differ in prevalence between centres. We therefore typed HLA-DRB1 and DQB1 in 340 UK, 139 Dutch and 163 Japanese sarcoidosis patients and, respectively, 354, 218 and 168 healthy controls from these populations. We applied consistent phenotyping and genotyping and investigated associations between HLA class II alleles and distinct disease phenotypes within and between ethnic groups. DRB1*01 and DQB1*0501 are protective against all manifestations of sarcoidosis. Lung-predominant sarcoidosis is associated with DRB1*12 and *14 . Löfgren's syndrome is a common sarcoidosis phenotype in the Dutch and is strongly associated with the DRB1*0301 allele. This phenotype is not seen among the Japanese in whom DRB1*0301 is absent. The same allele is protective for UK uveitis. Sarcoid uveitis is common in Japan. The DRB1*04–DQB1*0301 haplotype is a risk factor for this disease manifestation in Japanese and UK subjects but protective for sarcoidosis overall. We show that distinct sarcoidosis phenotypes have similar genetic associations across ethnic groups. The disease case mix differs between centres and may be explained by different ethnic allelic frequencies.
Author Newman, Lee S.
van den Bosch, Jules M.M.
Nagai, Sonoko
Woodhead, Felix A.
Spagnolo, Paolo
Izumi, Takateru
du Bois, Roland M.
Ahmad, Tariq
Grutters, Jan C.
Wells, Athol U.
Sato, Hiroe
Maier, Lisa A.
Welsh, Kenneth I.
Author_xml – sequence: 1
  givenname: Hiroe
  surname: Sato
  fullname: Sato, Hiroe
  email: h.sato@imperial.ac.uk
  organization: Clinical Genomics Group, Imperial College London, London SW3 6LR, UK
– sequence: 2
  givenname: Felix A.
  surname: Woodhead
  fullname: Woodhead, Felix A.
  organization: Clinical Genomics Group, Imperial College London, London SW3 6LR, UK
– sequence: 3
  givenname: Tariq
  surname: Ahmad
  fullname: Ahmad, Tariq
  organization: Department of Gastroenterology, Peninsula Medical School, Exeter EX2 5DW, UK
– sequence: 4
  givenname: Jan C.
  surname: Grutters
  fullname: Grutters, Jan C.
  organization: Heart Lung Center Utrecht, Department of Pulmonology, St Antonius Hospital, Nieuwegein 3430 RM, The Netherlands
– sequence: 5
  givenname: Paolo
  surname: Spagnolo
  fullname: Spagnolo, Paolo
  organization: Clinical Genomics Group, Imperial College London, London SW3 6LR, UK
– sequence: 6
  givenname: Jules M.M.
  surname: van den Bosch
  fullname: van den Bosch, Jules M.M.
  organization: Heart Lung Center Utrecht, Department of Pulmonology, St Antonius Hospital, Nieuwegein 3430 RM, The Netherlands
– sequence: 7
  givenname: Lisa A.
  surname: Maier
  fullname: Maier, Lisa A.
  organization: Division of Environmental and Occupational Health Sciences, Department of Medicine, National Jewish Health, Denver, CO 80206, USA
– sequence: 8
  givenname: Lee S.
  surname: Newman
  fullname: Newman, Lee S.
  organization: Department of Environmental and Occupational Health
– sequence: 9
  givenname: Sonoko
  surname: Nagai
  fullname: Nagai, Sonoko
  organization: Central Clinic in Kyoto, Kyoto 604-8111, Japan
– sequence: 10
  givenname: Takateru
  surname: Izumi
  fullname: Izumi, Takateru
  organization: Central Clinic in Kyoto, Kyoto 604-8111, Japan
– sequence: 11
  givenname: Athol U.
  surname: Wells
  fullname: Wells, Athol U.
  organization: Clinical Genomics Group, Imperial College London, London SW3 6LR, UK
– sequence: 12
  givenname: Roland M.
  surname: du Bois
  fullname: du Bois, Roland M.
  organization: Clinical Genomics Group, Imperial College London, London SW3 6LR, UK
– sequence: 13
  givenname: Kenneth I.
  surname: Welsh
  fullname: Welsh, Kenneth I.
  organization: Clinical Genomics Group, Imperial College London, London SW3 6LR, UK
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23288570$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/20685690$$D View this record in MEDLINE/PubMed
BookMark eNqFkstu1DAUhi1URKeFDQ-AskFISKG-O9kgtRUwIw2w4NKKjeVx7MSQsVM7QfTt8ZBhuAiJ1bF1vv_XuZ2AIx-8AeAhgs8QrMlZt23PmuaGYHYHLBDlsMSwIkdgAWtOS15DfgxOUvoMIeKUiHvgGENesZxYgO6dijq4JiSXiuX6vNC9SqlYrYrW-DDeDs63RePSmOPkUmdS_llrovE6v4PNAuedVn0xdLPCFErHkE3M2OVM0cYwDek-uGtVn8yDfTwFH16-eH-5LNdvX60uz9elZpSMJSObqhaYoGZjVK04txZCgxE0ivKqVlYr1uSOMNe64ZpTyqoNrRWmBlorNDkFz2ffYdpsTaONH6Pq5RDdVsVbGZSTf2a862QbvkpKGCKCZ4Mne4MYbiaTRrl1SZu-V96EKcmaUSYYwtV_ScE4rkWNaCYf_V7UoZqfe8jA4z2gUp6ljcprl35xBFcVEzvu6cz9mHA09oAgKHfHIPMxyPkYMgz_grUb1ejCrnHX_1tSzpK8cfPtYK7iF8kFEUwurz_JK_j6o7h-cyGvyHeWE8pz
CitedBy_id crossref_primary_10_1159_000496384
crossref_primary_10_1080_24725625_2019_1681635
crossref_primary_10_18794_aams_167944
crossref_primary_10_1007_s00441_016_2526_3
crossref_primary_10_1111_joim_13629
crossref_primary_10_3390_cardiogenetics14020009
crossref_primary_10_1183_13993003_02002_2017
crossref_primary_10_5200_sm_hs_2018_038
crossref_primary_10_1016_j_jaut_2023_103107
crossref_primary_10_1111_jce_12401
crossref_primary_10_1080_09273948_2016_1196713
crossref_primary_10_1097_ICU_0b013e32834bbd7e
crossref_primary_10_4414_SMW_2022_w30049
crossref_primary_10_1016_j_humimm_2013_07_009
crossref_primary_10_1177_11795735241274186
crossref_primary_10_3389_fgene_2018_00503
crossref_primary_10_3389_fimmu_2021_746996
crossref_primary_10_3390_medicina58070898
crossref_primary_10_1016_j_medcli_2014_02_029
crossref_primary_10_1165_rcmb_2014_0227OC
crossref_primary_10_1111_resp_12917
crossref_primary_10_1183_13993003_00050_2018
crossref_primary_10_1055_s_0040_1710536
crossref_primary_10_1097_LBR_0000000000000358
crossref_primary_10_1136_postgradmedj_2014_132584
crossref_primary_10_1111_ceo_14366
crossref_primary_10_1164_rccm_201407_1341OC
crossref_primary_10_1038_s41598_022_13199_w
crossref_primary_10_1111_pace_12277
crossref_primary_10_1586_eci_13_8
crossref_primary_10_1016_j_preteyeres_2011_06_005
crossref_primary_10_1093_hmg_ddad067
crossref_primary_10_1016_j_rmed_2017_09_014
crossref_primary_10_1007_s12016_015_8477_8
crossref_primary_10_1016_j_iac_2012_08_004
crossref_primary_10_1016_j_heliyon_2024_e27612
crossref_primary_10_1016_j_revmed_2017_09_007
crossref_primary_10_1016_j_revmed_2016_01_010
crossref_primary_10_3389_fimmu_2019_02964
crossref_primary_10_1016_S0140_6736_13_60680_7
crossref_primary_10_1016_j_jaut_2017_12_012
crossref_primary_10_1155_2017_3642832
crossref_primary_10_1183_13993003_00385_2018
crossref_primary_10_1186_s13023_016_0546_4
crossref_primary_10_1007_s10741_012_9358_3
crossref_primary_10_1111_hepr_12021
crossref_primary_10_1183_09031936_00035213
crossref_primary_10_1097_MCP_0000000000000077
crossref_primary_10_1016_j_autrev_2014_04_001
crossref_primary_10_2174_1566523223666230119143501
crossref_primary_10_1097_MCP_0000000000000798
crossref_primary_10_2336_nishinihonhifu_85_104
crossref_primary_10_1016_j_jbspin_2019_10_001
crossref_primary_10_1007_s12016_015_8481_z
crossref_primary_10_1097_ICU_0b013e32834cb7d7
crossref_primary_10_1016_j_jaut_2023_103122
crossref_primary_10_1586_eci_11_76
crossref_primary_10_1172_JCI175264
crossref_primary_10_1186_s12929_019_0537_6
crossref_primary_10_1165_rcmb_2018_0177OC
crossref_primary_10_1183_09031936_00025011
crossref_primary_10_1136_postgradmedj_2014_133219
crossref_primary_10_1177_039463201402700302
crossref_primary_10_1186_s12950_015_0066_3
crossref_primary_10_3389_fimmu_2017_00422
crossref_primary_10_1016_j_jfo_2018_10_002
crossref_primary_10_1016_j_humimm_2011_10_016
crossref_primary_10_1371_journal_pone_0223897
crossref_primary_10_1097_MCP_0000000000000189
crossref_primary_10_3390_jcm9082633
crossref_primary_10_1016_j_gene_2024_148706
crossref_primary_10_1111_tan_12326
crossref_primary_10_1111_crj_12559
crossref_primary_10_1016_j_jfo_2018_06_015
crossref_primary_10_1038_s42003_020_01185_9
crossref_primary_10_1080_09273948_2019_1705985
crossref_primary_10_1093_rheumatology_keu381
crossref_primary_10_31083_j_rcm_2020_03_102
crossref_primary_10_1016_j_ejim_2020_04_024
crossref_primary_10_3390_jcm10102146
crossref_primary_10_1080_00325481_2017_1251818
crossref_primary_10_1186_s12931_022_02085_8
crossref_primary_10_7861_clinmedicine_16_1_34
crossref_primary_10_1016_j_jaut_2025_103375
crossref_primary_10_1253_circj_CJ_19_0508
crossref_primary_10_3389_fmed_2023_1094843
crossref_primary_10_1007_s00408_023_00626_6
crossref_primary_10_3389_fphar_2014_00233
crossref_primary_10_1016_j_ccm_2015_08_002
crossref_primary_10_1016_j_cyto_2014_05_020
crossref_primary_10_1016_j_jneuroim_2022_577957
crossref_primary_10_1167_tvst_2_2_1
crossref_primary_10_3390_jcm9082363
crossref_primary_10_1186_1479_5876_12_152
Cites_doi 10.1034/j.1399-0039.2000.560606.x
10.1111/j.1399-0039.1995.tb03127.x
10.1165/rcmb.2003-0007OC
10.1038/ng1519
10.1165/rcmb.4782
10.1164/ajrccm.165.8.200110-0320
10.1164/rccm.200412-1707OC
10.1056/NEJM199704243361706
10.1186/1465-9921-6-94
10.1093/hmg/ddg066
10.1034/j.1399-3003.1999.14d02.x
10.1007/s10875-009-9311-y
10.1136/thorax.55.9.751
10.1164/rccm.200402-249OC
10.1164/rccm.200209-1097OC
10.1111/j.1365-2796.2007.01829.x
10.1016/S0198-8859(02)00437-8
10.1111/j.1399-0039.2007.00842.x
10.1136/thorax.57.4.348
10.1111/j.1399-0039.2007.00879.x
10.1164/rccm.200303-459OC
10.1002/ajim.20045
10.1034/j.1399-0039.2000.560107.x
10.1165/ajrcmb.25.3.4261
10.1034/j.1399-0039.2001.057001087.x
10.1164/ajrccm.156.5.9704069
10.1164/ajrccm.165.6.2104002
10.1016/S0198-8859(01)00261-0
10.1016/j.humimm.2008.05.011
10.1183/09031936.01.00106201
10.1164/ajrccm.152.2.7633707
10.1093/hmg/ddp521
10.1164/ajrccm.162.3.9901099
10.1164/rccm.200303-456OC
10.1111/j.1399-0039.2005.00370.x
10.1086/378097
10.4049/jimmunol.171.12.6910
10.1016/S0012-3692(15)37948-4
ContentType Journal Article
Copyright 2015 INIST-CNRS
The Author 2010. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org 2010
Copyright_xml – notice: 2015 INIST-CNRS
– notice: The Author 2010. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org 2010
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
8FD
FR3
P64
RC3
5PM
DOI 10.1093/hmg/ddq325
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Genetics Abstracts
Engineering Research Database
Technology Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitleList
MEDLINE
Genetics Abstracts
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1460-2083
EndPage 4111
ExternalDocumentID PMC4351376
20685690
23288570
10_1093_hmg_ddq325
ark_67375_HXZ_W0MV7XNB_W
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: NCRR NIH HHS
  grantid: UL1 RR025780
GroupedDBID ---
-DZ
-E4
.2P
.I3
.XZ
.ZR
0R~
18M
1TH
29I
2WC
4.4
482
48X
53G
5GY
5RE
5VS
5WA
5WD
70D
AABZA
AACZT
AAIMJ
AAJKP
AAJQQ
AAMDB
AAMVS
AAOGV
AAPNW
AAPQZ
AAPXW
AARHZ
AAUAY
AAUQX
AAVAP
AAVLN
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABLJU
ABMNT
ABNGD
ABNHQ
ABNKS
ABPQP
ABPTD
ABQLI
ABVGC
ABWST
ABXVV
ABXZS
ABZBJ
ACGFO
ACGFS
ACPRK
ACUFI
ACUKT
ACUTJ
ACUTO
ADBBV
ADEYI
ADEZT
ADFTL
ADGKP
ADGZP
ADHKW
ADHZD
ADIPN
ADNBA
ADOCK
ADQBN
ADRTK
ADVEK
ADYVW
ADZTZ
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AELWJ
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFNX
AFFZL
AFGWE
AFIYH
AFOFC
AFYAG
AGINJ
AGKEF
AGORE
AGQPQ
AGQXC
AGSYK
AHMBA
AHMMS
AHXPO
AIAGR
AIJHB
AJBYB
AJEEA
AJNCP
AKHUL
AKWXX
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APWMN
ARIXL
ASPBG
ATGXG
AVWKF
AXUDD
AYOIW
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BQDIO
BSCLL
BSWAC
BTRTY
BVRKM
C1A
C45
CAG
CDBKE
COF
CS3
CZ4
DAKXR
DIK
DILTD
DU5
D~K
EBS
EE~
EJD
EMOBN
F5P
F9B
FEDTE
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HVGLF
HW0
HZ~
IH2
IOX
J21
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
M-Z
ML0
N9A
NGC
NLBLG
NOMLY
NOYVH
NU-
NVLIB
O0~
O9-
OAWHX
OBC
OBOKY
OBS
OCZFY
ODMLO
OEB
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
R44
RD5
ROL
ROX
ROZ
RUSNO
RW1
RXO
SJN
TEORI
TJX
TLC
TMA
TR2
W8F
WOQ
X7H
XSW
YAYTL
YKOAZ
YXANX
ZKX
~91
AAYOK
AAYXX
CITATION
.55
.GJ
AAPGJ
AAWDT
ABEFU
ABIME
ABPIB
ABSMQ
ABZEO
ACFRR
ACPQN
ACVCV
ACZBC
ADMTO
AEHUL
AEKPW
AFFQV
AFSHK
AGKRT
AGMDO
AHGBF
AJDVS
ANFBD
APJGH
AQDSO
AQKUS
ASAOO
ATDFG
ATTQO
AVNTJ
BZKNY
CXTWN
DFGAJ
EIHJH
ELUNK
IQODW
MBLQV
MBTAY
NEJ
NTWIH
OBFPC
O~Y
QBD
RIG
RNI
RZF
RZO
TCN
X7M
ZCG
ZGI
ZXP
ZY4
CGR
CUY
CVF
ECM
EIF
NPM
7X8
8FD
FR3
P64
RC3
5PM
ID FETCH-LOGICAL-c543t-53b897231dbea9a66ff00e210ea4689afca5d90626ccd6c64458b49a24e0ff7c3
ISSN 0964-6906
1460-2083
IngestDate Thu Aug 21 13:59:27 EDT 2025
Fri Jul 11 04:04:36 EDT 2025
Fri Jul 11 11:44:41 EDT 2025
Mon Jul 21 06:08:08 EDT 2025
Mon Jul 21 09:13:58 EDT 2025
Tue Jul 01 00:24:09 EDT 2025
Thu Apr 24 22:59:28 EDT 2025
Tue Aug 05 16:49:35 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 20
Keywords Phenotype
Sarcoidosis
Systemic disease
Class II histocompatibility antigen
Genotype
Genetics
Ethnic group
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c543t-53b897231dbea9a66ff00e210ea4689afca5d90626ccd6c64458b49a24e0ff7c3
Notes href:ddq325.pdf
ark:/67375/HXZ-W0MV7XNB-W
ArticleID:ddq325
istex:CE9CDF45C7B16DCBC7380AC64E34BEA1B6D1A3B7
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink https://academic.oup.com/hmg/article-pdf/19/20/4100/17250101/ddq325.pdf
PMID 20685690
PQID 756297914
PQPubID 23479
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4351376
proquest_miscellaneous_954575128
proquest_miscellaneous_756297914
pubmed_primary_20685690
pascalfrancis_primary_23288570
crossref_primary_10_1093_hmg_ddq325
crossref_citationtrail_10_1093_hmg_ddq325
istex_primary_ark_67375_HXZ_W0MV7XNB_W
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-10-15
PublicationDateYYYYMMDD 2010-10-15
PublicationDate_xml – month: 10
  year: 2010
  text: 2010-10-15
  day: 15
PublicationDecade 2010
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: England
PublicationTitle Human molecular genetics
PublicationTitleAlternate Hum Mol Genet
PublicationYear 2010
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References Kreider ( key 20170522124737_DDQ325C24) 2005; 128
Grunewald ( key 20170522124737_DDQ325C38) 2002; 57
McGrath ( key 20170522124737_DDQ325C4) 2000; 55
Ishihara ( key 20170522124737_DDQ325C16) 1996; 40
Rossman ( key 20170522124737_DDQ325C19) 2003; 73
Valentonyte ( key 20170522124737_DDQ325C39) 2005; 37
Berlin ( key 20170522124737_DDQ325C12) 1997; 156
Naruse ( key 20170522124737_DDQ325C32) 2000; 56
Grutters ( key 20170522124737_DDQ325C40) 2002; 165
Amicosante ( key 20170522124737_DDQ325C6) 2001; 62
Schurmann ( key 20170522124737_DDQ325C5) 2000; 162
Newman ( key 20170522124737_DDQ325C25) 2004; 170
Yamaguchi ( key 20170522124737_DDQ325C23) 1994; 52
Spagnolo ( key 20170522124737_DDQ325C28) 2007; 70
Mrazek ( key 20170522124737_DDQ325C18) 2005; 65
Spagnolo ( key 20170522124737_DDQ325C26) 2003; 168
Karp ( key 20170522124737_DDQ325C37) 2010; 19
Rossman ( key 20170522124737_DDQ325C10) 2002; 165
Ahmad ( key 20170522124737_DDQ325C29) 2003; 12
Newman ( key 20170522124737_DDQ325C3) 1997; 336
Maier ( key 20170522124737_DDQ325C8) 2003; 171
Saltini ( key 20170522124737_DDQ325C11) 2001; 18
Sato ( key 20170522124737_DDQ325C21) 2002; 27
Saito ( key 20170522124737_DDQ325C33) 2000; 56
Welsh ( key 20170522124737_DDQ325C44) 1999; 1
Grunewald ( key 20170522124737_DDQ325C31) 2004; 169
Voorter ( key 20170522124737_DDQ325C36) 2007; 70
Ishihara ( key 20170522124737_DDQ325C15) 1996; 40
Bunce ( key 20170522124737_DDQ325C43) 1995; 46
Carrington ( key 20170522124737_DDQ325C34) 2002; 63
Sato ( key 20170522124737_DDQ325C45) 2007; 262
Grutters ( key 20170522124737_DDQ325C41) 2003; 20
Spagnolo ( key 20170522124737_DDQ325C42) 2005; 172
McCanlies ( key 20170522124737_DDQ325C9) 2004; 46
Bogunia-Kubik ( key 20170522124737_DDQ325C30) 2001; 57
Iannuzzi ( key 20170522124737_DDQ325C14) 2003; 167
Kanterakis ( key 20170522124737_DDQ325C27) 2008; 69
Amicosante ( key 20170522124737_DDQ325C7) 2005; 6
Rutherford ( key 20170522124737_DDQ325C20) 2004; 21
Oswald-Richter ( key 20170522124737_DDQ325C35) 2010; 30
Costabel ( key 20170522124737_DDQ325C2) 1999; 14
Foley ( key 20170522124737_DDQ325C13) 2001; 25
Sharma ( key 20170522124737_DDQ325C22) 2003; 29
Hillerdal ( key 20170522124737_DDQ325C1) 1984; 130
Martinetti ( key 20170522124737_DDQ325C17) 1995; 152
15554075 - Sarcoidosis Vasc Diffuse Lung Dis. 2004 Oct;21(3):191-8
12615619 - Am J Respir Crit Care Med. 2003 May 1;167(9):1225-31
7633707 - Am J Respir Crit Care Med. 1995 Aug;152(2):557-64
16098233 - Respir Res. 2005 Aug 14;6:94
10988096 - Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):861-4
10573213 - Eur Respir J. 1999 Oct;14(4):735-7
12737276 - Sarcoidosis Vasc Diffuse Lung Dis. 2003 Mar;20(1):20-7
11716174 - Eur Respir J. 2001 Oct;18(4):677-84
15713215 - Tissue Antigens. 2005 Feb;65(2):163-71
12600814 - Am J Respir Cell Mol Biol. 2003 Aug;29(2):225-31
15273960 - Am J Ind Med. 2004 Aug;46(2):95-103
11169242 - Tissue Antigens. 2000 Dec;56(6):522-9
11253945 - Rev Immunogenet. 1999;1(2):157-76
8739505 - Jpn J Ophthalmol. 1996;40(1):86-94
11588003 - Am J Respir Cell Mol Biol. 2001 Sep;25(3):272-7
14662898 - J Immunol. 2003 Dec 15;171(12):6910-8
17559577 - Tissue Antigens. 2007 Jul;70(1):18-27
18601964 - Hum Immunol. 2008 Aug;69(8):522-5
19536643 - J Clin Immunol. 2010 Jan;30(1):157-66
15735647 - Nat Genet. 2005 Apr;37(4):357-64
10950893 - Thorax. 2000 Sep;55(9):751-4
11956055 - Am J Respir Crit Care Med. 2002 Apr 15;165(8):1119-24
9372682 - Am J Respir Crit Care Med. 1997 Nov;156(5):1601-5
11923555 - Thorax. 2002 Apr;57(4):348-52
15347561 - Am J Respir Crit Care Med. 2004 Dec 15;170(12):1324-30
12392858 - Hum Immunol. 2002 Nov;63(11):1045-54
11169267 - Tissue Antigens. 2001 Jan;57(1):87-90
11897645 - Am J Respir Crit Care Med. 2002 Mar 15;165(6):788-94
12356573 - Am J Respir Cell Mol Biol. 2002 Oct;27(4):406-12
9130059 - Jpn J Ophthalmol. 1996;40(4):540-3
8046821 - Nihon Rinsho. 1994 Jun;52(6):1443-8
19933168 - Hum Mol Genet. 2010 Feb 15;19(4):707-19
16002937 - Chest. 2005 Jul;128(1):207-15
8838344 - Tissue Antigens. 1995 Nov;46(5):355-67
14508706 - Am J Hum Genet. 2003 Oct;73(4):720-35
9110911 - N Engl J Med. 1997 Apr 24;336(17):1224-34
11423174 - Hum Immunol. 2001 Jul;62(7):686-93
17661910 - Tissue Antigens. 2007 Sep;70(3):219-27
12620970 - Hum Mol Genet. 2003 Mar 15;12(6):647-56
15976369 - Am J Respir Crit Care Med. 2005 Sep 15;172(6):721-8
17875181 - J Intern Med. 2007 Oct;262(4):449-57
12882757 - Am J Respir Crit Care Med. 2003 Nov 15;168(10):1162-6
10958356 - Tissue Antigens. 2000 Jul;56(1):52-7
6742607 - Am Rev Respir Dis. 1984 Jul;130(1):29-32
14656748 - Am J Respir Crit Care Med. 2004 Mar 15;169(6):696-702
References_xml – volume: 56
  start-page: 522
  year: 2000
  ident: key 20170522124737_DDQ325C33
  article-title: Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population
  publication-title: Tissue Antigens
  doi: 10.1034/j.1399-0039.2000.560606.x
– volume: 1
  start-page: 157
  year: 1999
  ident: key 20170522124737_DDQ325C44
  article-title: Molecular typing for the MHC with PCR-SSP
  publication-title: Rev. Immunogenet.
– volume: 46
  start-page: 355
  year: 1995
  ident: key 20170522124737_DDQ325C43
  article-title: Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP)
  publication-title: Tissue Antigens
  doi: 10.1111/j.1399-0039.1995.tb03127.x
– volume: 40
  start-page: 540
  year: 1996
  ident: key 20170522124737_DDQ325C15
  article-title: HLA class II genotyping of sarcoidosis patients in Hokkaido by PCR-RFLP
  publication-title: Jpn J. Ophthalmol.
– volume: 21
  start-page: 191
  year: 2004
  ident: key 20170522124737_DDQ325C20
  article-title: HLA-DR2 predicts susceptibility and disease chronicity in Irish sarcoidosis patients
  publication-title: Sarcoidosis Vasc. Diffuse Lung Dis.
– volume: 29
  start-page: 225
  year: 2003
  ident: key 20170522124737_DDQ325C22
  article-title: Human leukocyte antigen-DR alleles influence the clinical course of pulmonary sarcoidosis in Asian Indians
  publication-title: Am. J. Respir. Cell Mol. Biol.
  doi: 10.1165/rcmb.2003-0007OC
– volume: 37
  start-page: 357
  year: 2005
  ident: key 20170522124737_DDQ325C39
  article-title: Sarcoidosis is associated with a truncating splice site mutation in BTNL2
  publication-title: Nat. Genet.
  doi: 10.1038/ng1519
– volume: 27
  start-page: 406
  year: 2002
  ident: key 20170522124737_DDQ325C21
  article-title: HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis
  publication-title: Am. J. Respir. Cell Mol. Biol.
  doi: 10.1165/rcmb.4782
– volume: 165
  start-page: 1119
  year: 2002
  ident: key 20170522124737_DDQ325C40
  article-title: Increased frequency of the uncommon tumor necrosis factor −857T allele in British and Dutch patients with sarcoidosis
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/ajrccm.165.8.200110-0320
– volume: 172
  start-page: 721
  year: 2005
  ident: key 20170522124737_DDQ325C42
  article-title: C-C chemokine receptor 5 gene variants in relation to lung disease in sarcoidosis
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/rccm.200412-1707OC
– volume: 336
  start-page: 1224
  year: 1997
  ident: key 20170522124737_DDQ325C3
  article-title: Sarcoidosis
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM199704243361706
– volume: 6
  start-page: 94
  year: 2005
  ident: key 20170522124737_DDQ325C7
  article-title: Identification of HLA-DRPhebeta47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlubeta69
  publication-title: Respir. Res.
  doi: 10.1186/1465-9921-6-94
– volume: 12
  start-page: 647
  year: 2003
  ident: key 20170522124737_DDQ325C29
  article-title: Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddg066
– volume: 14
  start-page: 735
  year: 1999
  ident: key 20170522124737_DDQ325C2
  article-title: ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders
  publication-title: Eur. Respir. J.
  doi: 10.1034/j.1399-3003.1999.14d02.x
– volume: 52
  start-page: 1443
  year: 1994
  ident: key 20170522124737_DDQ325C23
  article-title: Analysis of HLA antigen in Japanese patients with sarcoidosis
  publication-title: Nippon Rinsho
– volume: 30
  start-page: 157
  year: 2010
  ident: key 20170522124737_DDQ325C35
  article-title: Mycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4+ T cells when presented by the American sarcoidosis susceptibility allele, DRB1*1101
  publication-title: J. Clin. Immunol.
  doi: 10.1007/s10875-009-9311-y
– volume: 55
  start-page: 751
  year: 2000
  ident: key 20170522124737_DDQ325C4
  article-title: Epidemiology of familial sarcoidosis in the UK
  publication-title: Thorax
  doi: 10.1136/thorax.55.9.751
– volume: 170
  start-page: 1324
  year: 2004
  ident: key 20170522124737_DDQ325C25
  article-title: A case control etiologic study of sarcoidosis: environmental and occupational risk factors
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/rccm.200402-249OC
– volume: 167
  start-page: 1225
  year: 2003
  ident: key 20170522124737_DDQ325C14
  article-title: Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/rccm.200209-1097OC
– volume: 262
  start-page: 449
  year: 2007
  ident: key 20170522124737_DDQ325C45
  article-title: HLA-DQB1 0602 allele is associated with splenomegaly in Japanese sarcoidosis
  publication-title: J. Intern. Med.
  doi: 10.1111/j.1365-2796.2007.01829.x
– volume: 63
  start-page: 1045
  year: 2002
  ident: key 20170522124737_DDQ325C34
  article-title: A comparison of HLA-DR and -DQ allele and haplotype frequencies in Trinidadian populations of African, South Asian, and mixed ancestry
  publication-title: Hum. Immunol.
  doi: 10.1016/S0198-8859(02)00437-8
– volume: 70
  start-page: 18
  year: 2007
  ident: key 20170522124737_DDQ325C36
  article-title: HLA class II amino acid epitopes as susceptibility markers of sarcoidosis
  publication-title: Tissue Antigens
  doi: 10.1111/j.1399-0039.2007.00842.x
– volume: 57
  start-page: 348
  year: 2002
  ident: key 20170522124737_DDQ325C38
  article-title: Lung restricted T cell receptor AV2S3+ CD4+ T cell expansions in sarcoidosis patients with a shared HLA-DRbeta chain conformation
  publication-title: Thorax
  doi: 10.1136/thorax.57.4.348
– volume: 130
  start-page: 29
  year: 1984
  ident: key 20170522124737_DDQ325C1
  article-title: Sarcoidosis: epidemiology and prognosis. A 15-year European study
  publication-title: Am. Rev. Respir. Dis.
– volume: 70
  start-page: 219
  year: 2007
  ident: key 20170522124737_DDQ325C28
  article-title: Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis
  publication-title: Tissue Antigens
  doi: 10.1111/j.1399-0039.2007.00879.x
– volume: 169
  start-page: 696
  year: 2004
  ident: key 20170522124737_DDQ325C31
  article-title: Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/rccm.200303-459OC
– volume: 46
  start-page: 95
  year: 2004
  ident: key 20170522124737_DDQ325C9
  article-title: The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization
  publication-title: Am. J. Ind. Med.
  doi: 10.1002/ajim.20045
– volume: 56
  start-page: 52
  year: 2000
  ident: key 20170522124737_DDQ325C32
  article-title: HLA-DQB1*0601 is primarily associated with the susceptibility to cardiac sarcoidosis
  publication-title: Tissue Antigens
  doi: 10.1034/j.1399-0039.2000.560107.x
– volume: 25
  start-page: 272
  year: 2001
  ident: key 20170522124737_DDQ325C13
  article-title: Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis
  publication-title: Am. J. Respir. Cell Mol. Biol.
  doi: 10.1165/ajrcmb.25.3.4261
– volume: 57
  start-page: 87
  year: 2001
  ident: key 20170522124737_DDQ325C30
  article-title: HLA-DRB1*03, DRB1*11 or DRB1*12 and their respective DRB3 specificities in clinical variants of sarcoidosis
  publication-title: Tissue Antigens
  doi: 10.1034/j.1399-0039.2001.057001087.x
– volume: 20
  start-page: 20
  year: 2003
  ident: key 20170522124737_DDQ325C41
  article-title: Analysis of IL6 and IL1A gene polymorphisms in UK and Dutch patients with sarcoidosis
  publication-title: Sarcoidosis Vasc. Diffuse Lung Dis.
– volume: 156
  start-page: 1601
  year: 1997
  ident: key 20170522124737_DDQ325C12
  article-title: HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/ajrccm.156.5.9704069
– volume: 165
  start-page: 788
  year: 2002
  ident: key 20170522124737_DDQ325C10
  article-title: Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/ajrccm.165.6.2104002
– volume: 62
  start-page: 686
  year: 2001
  ident: key 20170522124737_DDQ325C6
  article-title: Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69
  publication-title: Hum. Immunol.
  doi: 10.1016/S0198-8859(01)00261-0
– volume: 69
  start-page: 522
  year: 2008
  ident: key 20170522124737_DDQ325C27
  article-title: SKDM human leukocyte antigen (HLA) tool: a comprehensive HLA and disease associations analysis software
  publication-title: Hum. Immunol.
  doi: 10.1016/j.humimm.2008.05.011
– volume: 18
  start-page: 677
  year: 2001
  ident: key 20170522124737_DDQ325C11
  article-title: Major histocompatibility locus genetic markers of beryllium sensitization and disease
  publication-title: Eur. Respir. J.
  doi: 10.1183/09031936.01.00106201
– volume: 152
  start-page: 557
  year: 1995
  ident: key 20170522124737_DDQ325C17
  article-title: ‘The sarcoidosis map’: a joint survey of clinical and immunogenetic findings in two European countries
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/ajrccm.152.2.7633707
– volume: 19
  start-page: 707
  year: 2010
  ident: key 20170522124737_DDQ325C37
  article-title: Novel sequence feature variant type analysis of the HLA genetic association in systemic sclerosis
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddp521
– volume: 162
  start-page: 861
  year: 2000
  ident: key 20170522124737_DDQ325C5
  article-title: Familial sarcoidosis is linked to the major histocompatibility complex region
  publication-title: Am. J. Respir. Crit. Care. Med.
  doi: 10.1164/ajrccm.162.3.9901099
– volume: 168
  start-page: 1162
  year: 2003
  ident: key 20170522124737_DDQ325C26
  article-title: C-C chemokine receptor 2 and sarcoidosis: association with Lofgren's syndrome
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/rccm.200303-456OC
– volume: 65
  start-page: 163
  year: 2005
  ident: key 20170522124737_DDQ325C18
  article-title: Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Lofgren's syndrome in Czech patients with sarcoidosis
  publication-title: Tissue Antigens
  doi: 10.1111/j.1399-0039.2005.00370.x
– volume: 73
  start-page: 720
  year: 2003
  ident: key 20170522124737_DDQ325C19
  article-title: HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites
  publication-title: Am. J. Hum. Genet.
  doi: 10.1086/378097
– volume: 171
  start-page: 6910
  year: 2003
  ident: key 20170522124737_DDQ325C8
  article-title: Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.171.12.6910
– volume: 128
  start-page: 207
  year: 2005
  ident: key 20170522124737_DDQ325C24
  article-title: Relationship of environmental exposures to the clinical phenotype of sarcoidosis
  publication-title: Chest
  doi: 10.1016/S0012-3692(15)37948-4
– volume: 40
  start-page: 86
  year: 1996
  ident: key 20170522124737_DDQ325C16
  article-title: HLA serological and class II genotyping in sarcoidosis patients in Japan
  publication-title: Jpn. J. Ophthalmol.
– reference: 11423174 - Hum Immunol. 2001 Jul;62(7):686-93
– reference: 15713215 - Tissue Antigens. 2005 Feb;65(2):163-71
– reference: 18601964 - Hum Immunol. 2008 Aug;69(8):522-5
– reference: 12882757 - Am J Respir Crit Care Med. 2003 Nov 15;168(10):1162-6
– reference: 9110911 - N Engl J Med. 1997 Apr 24;336(17):1224-34
– reference: 10573213 - Eur Respir J. 1999 Oct;14(4):735-7
– reference: 17559577 - Tissue Antigens. 2007 Jul;70(1):18-27
– reference: 11716174 - Eur Respir J. 2001 Oct;18(4):677-84
– reference: 10958356 - Tissue Antigens. 2000 Jul;56(1):52-7
– reference: 11956055 - Am J Respir Crit Care Med. 2002 Apr 15;165(8):1119-24
– reference: 19536643 - J Clin Immunol. 2010 Jan;30(1):157-66
– reference: 9372682 - Am J Respir Crit Care Med. 1997 Nov;156(5):1601-5
– reference: 7633707 - Am J Respir Crit Care Med. 1995 Aug;152(2):557-64
– reference: 14656748 - Am J Respir Crit Care Med. 2004 Mar 15;169(6):696-702
– reference: 15347561 - Am J Respir Crit Care Med. 2004 Dec 15;170(12):1324-30
– reference: 16098233 - Respir Res. 2005 Aug 14;6:94
– reference: 11253945 - Rev Immunogenet. 1999;1(2):157-76
– reference: 12600814 - Am J Respir Cell Mol Biol. 2003 Aug;29(2):225-31
– reference: 12615619 - Am J Respir Crit Care Med. 2003 May 1;167(9):1225-31
– reference: 17661910 - Tissue Antigens. 2007 Sep;70(3):219-27
– reference: 14662898 - J Immunol. 2003 Dec 15;171(12):6910-8
– reference: 8838344 - Tissue Antigens. 1995 Nov;46(5):355-67
– reference: 10950893 - Thorax. 2000 Sep;55(9):751-4
– reference: 11923555 - Thorax. 2002 Apr;57(4):348-52
– reference: 19933168 - Hum Mol Genet. 2010 Feb 15;19(4):707-19
– reference: 6742607 - Am Rev Respir Dis. 1984 Jul;130(1):29-32
– reference: 12620970 - Hum Mol Genet. 2003 Mar 15;12(6):647-56
– reference: 15554075 - Sarcoidosis Vasc Diffuse Lung Dis. 2004 Oct;21(3):191-8
– reference: 10988096 - Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):861-4
– reference: 8046821 - Nihon Rinsho. 1994 Jun;52(6):1443-8
– reference: 11169267 - Tissue Antigens. 2001 Jan;57(1):87-90
– reference: 16002937 - Chest. 2005 Jul;128(1):207-15
– reference: 12392858 - Hum Immunol. 2002 Nov;63(11):1045-54
– reference: 12356573 - Am J Respir Cell Mol Biol. 2002 Oct;27(4):406-12
– reference: 15273960 - Am J Ind Med. 2004 Aug;46(2):95-103
– reference: 17875181 - J Intern Med. 2007 Oct;262(4):449-57
– reference: 11169242 - Tissue Antigens. 2000 Dec;56(6):522-9
– reference: 15976369 - Am J Respir Crit Care Med. 2005 Sep 15;172(6):721-8
– reference: 12737276 - Sarcoidosis Vasc Diffuse Lung Dis. 2003 Mar;20(1):20-7
– reference: 15735647 - Nat Genet. 2005 Apr;37(4):357-64
– reference: 11588003 - Am J Respir Cell Mol Biol. 2001 Sep;25(3):272-7
– reference: 11897645 - Am J Respir Crit Care Med. 2002 Mar 15;165(6):788-94
– reference: 9130059 - Jpn J Ophthalmol. 1996;40(4):540-3
– reference: 8739505 - Jpn J Ophthalmol. 1996;40(1):86-94
– reference: 14508706 - Am J Hum Genet. 2003 Oct;73(4):720-35
SSID ssj0016437
Score 2.3678987
Snippet The HLA class II (DRB1 and DQB1) associations with sarcoidosis have been studied by several groups but often without consistent results. In this paper, we...
The HLA class II ( DRB1 and DQB1 ) associations with sarcoidosis have been studied by several groups but often without consistent results. In this paper, we...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
istex
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 4100
SubjectTerms Alleles
Association Studies
Biological and medical sciences
Ethnic Groups
Fundamental and applied biological sciences. Psychology
Gene Frequency
Genes, MHC Class II
Genetic Association Studies
Genetic Markers
Genetic Predisposition to Disease
Genetics of eukaryotes. Biological and molecular evolution
Genome-Wide Association Study
Genotype
Haplotypes
HLA Antigens
HLA-DQ Antigens - genetics
HLA-DQ Antigens - immunology
HLA-DR Antigens - genetics
HLA-DR Antigens - immunology
HLA-DRB1 Chains
Humans
Japan
Medical sciences
Molecular and cellular biology
Netherlands
Phenotype
Polymerase Chain Reaction
Polymorphism, Genetic
Risk Factors
Sarcoidosis - ethnology
Sarcoidosis - genetics
Sarcoidosis - immunology
Sarcoidosis, Pulmonary - ethnology
Sarcoidosis, Pulmonary - genetics
Sarcoidosis, Pulmonary - immunology
Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
United Kingdom
Uveitis - ethnology
Uveitis - etiology
Title Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups
URI https://api.istex.fr/ark:/67375/HXZ-W0MV7XNB-W/fulltext.pdf
https://www.ncbi.nlm.nih.gov/pubmed/20685690
https://www.proquest.com/docview/756297914
https://www.proquest.com/docview/954575128
https://pubmed.ncbi.nlm.nih.gov/PMC4351376
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKJhAvCMYtXCZLICRUZXMS5-LHUqhaoBPSOlbxEjlOQirWZutF2vhZ_EKO7dRJoSDYS1Qldqz0fD4-xz7nfAi9dHmS-0Hq2Yw73AbtR23mJ7mdED8V0MN3uIryPQr6J_T92B-3Wj8aUUurZXIgvm_NK7mOVOEeyFVmyf6HZM1L4Qb8BvnCFSQM13-S8TGgtJykpSwq0v_YaQtpCrcHA8mLXC6vVCpUKifx7OtKxr4vDB-K0LVmTV6kjPQq1XYsV-tmO1sWkhpHJX0smhas3vWfrll15VAyD9KY5sdcETO1-5N5WZ_7lGVaVGjqZWeTy3bnwECtmOoHI3DbL-p4IMWgrVEGA3YPmvsTMtaD2DpD8295j82NyIDaslyyXpG0GqYBAUlrihujp1kDjy5paF3qENJYwWmlv39bHXTlrGIKSrSXpheeTrluAOV8qpDikiDyA0bqNdJELn4adsHAdEAt30C7LrgmkjXj7eCDObmSB6GqvmP1VeuSuMw7hIEP9bCyBHU1xoY9tCun9qWMz-ULEH6uuVW2OT-_xvA2jKLRXXSn8mZwR0PzHmplsz10U_ObXu2hW8MqcuM-KhpYxYBVrLCKBwNcYxVvYBU3sIrLHK-xig1WscYq1ljFGqsP0Env3ajbtyuWD1v41FvavpdEkvrOSZOMMx4EeU5I5jok4zSIGM9BYaSymnYgRBoIsN_9KKGMuzQjeR4K7yHamZWz7DHCIvKyMIu8hFKXspwkInF4ykQagtnLqGuh1-v_OhZVCXzJxHIW61AMLwYRxVpEFnph2p7rwi9bW71SIjNN-PybDJUM_bg__hKfkuHncHz0Jj610P6GTE0H8GgiSTJhIbwWcgwaXh7b8VlWrhZxCC4KC5lD_9yEgR8UgukeWeiRhkX9_gpnFgo3AGMayPrym09mk0LVma-A_uTaPZ-i27VGeIZ2lvNV9hxs-GWyrybNTwsm-1M
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sarcoidosis+HLA+class+II+genotyping+distinguishes+differences+of+clinical+phenotype+across+ethnic+groups&rft.jtitle=Human+molecular+genetics&rft.au=Sato%2C+Hiroe&rft.au=Woodhead%2C+Felix+A.&rft.au=Ahmad%2C+Tariq&rft.au=Grutters%2C+Jan+C.&rft.date=2010-10-15&rft.pub=Oxford+University+Press&rft.issn=0964-6906&rft.eissn=1460-2083&rft.volume=19&rft.issue=20&rft.spage=4100&rft.epage=4111&rft_id=info:doi/10.1093%2Fhmg%2Fddq325&rft_id=info%3Apmid%2F20685690&rft.externalDocID=PMC4351376
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0964-6906&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0964-6906&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0964-6906&client=summon